药品专利不侵权诉讼受理问题研究——质疑法释【2009】21号第18条  

Study on the Accepted Conditions forthe Non-infringement Action of Pharmaceutical Patent——Querying the article 18 of[2009]21 judicial interpretation

作　　者：丁锦希[1] 

机构地区：[1]中国药科大学,江苏南京211198

出　　处：《河北法学》2011年第3期93-99,共7页Hebei Law Science

基　　金：国家知识产权局软科学研究项目<创新药物研发的知识产权激励和保护政策研究>(SS09-A-26)的阶段性成果;项目负责人:丁锦希

摘　　要：在实现国家知识产权战略背景下,探讨修改专利法或其司法解释,明确药品专利不侵权诉讼案件的受理条件。基于专利法基本理论,运用案例分析、法条分析、经济分析及国内外法律制度比较分析等论证方法,剖析我国专利不侵权诉讼制度。根据国家知识产权战略,结合我国医药产业发展实际水平,适当拓宽药品专利不侵权诉讼的受理范围,提高药品的可及性。Discuss to make clear the conditions of admissibility by amending the patent law or the regulations under the background of accomplishing the national intellectual property strategy. Based on the fundamental theory of confirming non-infringement action , using case analysis,legal analysis,economic analysis and policy at home and abroad ana｜yzed and contrasted, anatomize the legal system of confirming non- infringement action in China. The author according to the national intellectual property strategy and combining with the actual level in the pharmaceutical industry, widen the accepted conditions for the non-infringement action of intellectual property , increase the availability of drugs.

关 键 词：药品专利 不侵权诉讼 国家知识产权战略 

分 类 号：D923.42[政治法律—民商法学]